UCM Stock Overview
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Uscom Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.031 |
52 Week High | AU$0.054 |
52 Week Low | AU$0.023 |
Beta | -0.94 |
1 Month Change | 3.33% |
3 Month Change | n/a |
1 Year Change | -31.11% |
3 Year Change | -80.63% |
5 Year Change | -82.29% |
Change since IPO | -98.71% |
Recent News & Updates
Shareholder Returns
UCM | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | -8.8% | 2.4% | 1.5% |
1Y | -31.1% | 27.7% | 11.6% |
Return vs Industry: UCM underperformed the Australian Medical Equipment industry which returned 27.7% over the past year.
Return vs Market: UCM underperformed the Australian Market which returned 11.6% over the past year.
Price Volatility
UCM volatility | |
---|---|
UCM Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 11.3% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 17.1% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: UCM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine UCM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Rob Phillips | https://www.uscom.com.au |
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a technology based on digital transit-time ultrasound comprising enhanced wireless and internet connectivity that allows clinicians to interface with several proprietary apps and software platforms; eHealth, which profiles cardiovascular and pulmonary function in a novel way; and respiratory devices.
Uscom Limited Fundamentals Summary
UCM fundamental statistics | |
---|---|
Market cap | AU$7.58m |
Earnings (TTM) | -AU$2.10m |
Revenue (TTM) | AU$3.36m |
2.3x
P/S Ratio-3.6x
P/E RatioIs UCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
UCM income statement (TTM) | |
---|---|
Revenue | AU$3.36m |
Cost of Revenue | AU$535.86k |
Gross Profit | AU$2.83m |
Other Expenses | AU$4.93m |
Earnings | -AU$2.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0086 |
Gross Margin | 84.06% |
Net Profit Margin | -62.47% |
Debt/Equity Ratio | 93.2% |
How did UCM perform over the long term?
See historical performance and comparison